Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliquis vs Lovenox for thromboprophylaxis in gynecologic cancer surgery
NCT02366871Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Apr 2015
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of apixaban in venous thromboembolism (VTE), sponsored by University of Colorado Denver. Started Apr 2015; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02366871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366871.